参考文献/References:
［1］ Writing group members, Lloyd- Jones D, Adams RJ, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association［J］. Circulation, 2010, 121: e46- e215.
［2］ Ducrocq G, Bhatt DL, Labreuche J, et al. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry［J］. Eur J Prev Cardiol, 2014, 21: 1509- 1516.
［3］ Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4- year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis［J］. JAMA, 2010, 304: 1350- 1357.
［4］ Bhatt DL, Peterson ED, Harrington RA, et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes［J］. Eur Heart J, 2009, 30: 1195- 1202.
［5］ Bertomeu V, Morillas P, Gonzalez- Juanatey JR, et al. Prevalence and prognostic influence of peripheral arterial disease in patients ≥40 years old admitted into hospital following an acute coronary event［J］. Eur J Vasc Endovasc Surg, 2008, 36: 189- 196.
［6］ Mukherjee D, Eagle KA, Kline- Rogers EA, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence- based therapies （from the global registry of acute coronary events）［J］. Am J Cardiol, 2007, 100: 1- 6.
［7］ Harskamp RE, Alexander JH, Schulte PJ, et al. Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery［J］. Ann Thorac Surg, 2014, 97: 824- 830.
［8］ Vardi M, Piazza G, Pencina MJ, et al. Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention［J］. Clin Appl Thromb Hemost, 2014, 20: 478- 483.
［9］ Collison T, Smith JM, Engel AM. Peripheral vascular disease and outcomes following coronary artery bypass graft surgery［J］. Arch Surg, 2006, 141: 1214- 1218.
［10］ Aboyans V, Lacroix P, Postil A, et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long- term prognostic factors in patients undergoing coronary artery bypass grafting［J］. J Am Coll Cardiol, 2005, 46: 815- 820.
［11］ Welten GM, Schouten O, Hoeks SE, et al. Long- term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease［J］. J Am Coll Cardiol, 2008, 51: 1588- 1596.
［12］ Norgren L, Hiatt WR, Dormandy JA, et al. Inter- society consensus for the management of peripheral arterial disease （TASCⅡ）［J］. Eur J Vasc Endovasc Surg, 2007, 33: S1- S75.
［13］ McFalls EO, Ward HB, Moritz TE, et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease:results of the CARP trial［J］. Eur Heart, 2008, 29: 394- 401.
［14］ Giugliano G, Di Serafino L, Perrino CA, et al. Effects of success- ful percutaneous lower extremity revascularization on cardiovas- cular outcome in patients with peripheral arterial disease［J］. Int J Cardiol, 2013, 167: 2566- 2571.
［15］ Giugliano G, Perrino C, Schiano V, et al. Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication［J］. BMC Surg, 2012, 12: S19.
［16］ Monaco M, Stassano P, Di Tommaso L, et al. Systematic strategy of prophylactic coronary angiography improves long- term outcome after major vascular surgery in medium to high- risk patients: a prospective, randomized study［J］. J Am Coll Cardiol, 2009, 54: 989- 996.
［17］ Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart asso- ciation task force on practice guidelines［J］. Circulation, 2009, 120: e169- e276.
［18］ Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre- operative cardiac risk assessment and perioperative cardiac mana- gement in non- cardiac surgery: the task force for preoperative cardiac risk assessment and perioperative cardiac management in non- cardiac surgery of the European Society of Cardiology（ESC） and endorsed by the European Society of Anaesthesiology（ESA）［J］. Eur J Anaesthesiol, 2010, 27: 92- 137.
［19］ Michos ED, Sibley CT, Baer JT, et al. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events reconciling the AIM- HIGH （atherothrombosis intervention in metabolic syndrome with low HDL/high triglycerides: impact on global health outcomes） trial with previous surrogate endpoint trials［J］. J Am Coll Cardiol, 2012, 59: 2058- 2064.
［20］ Diederichsen AC, Mahabadi AA, Gerke O, et al. Increased discor- dance between HeartScore and coronary artery calcification score after introduction of the new ESC prevention guidelines［J］. Atherosclerosis, 2015, 239: 143- 149.
［21］ Johnson KM, Dowe DA. Accuracy of statin assignment using the 2013 AHA/ACC cholesterol guideline versus the 2001 NCEP ATP Ⅲ guideline correlation with atherosclerotic plaque imaging［J］. J Am Coll Cardiol, 2014, 64: 910- 919.
［22］ Armstrong EJ, Chen DC, Westin GG, et al. Adherence to guideline- recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease［J］. J Am Heart Assoc, 2014, 3: e000697.
［23］ Cacoub PP, Abola MT, Baumgartner I, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the reduction of atherothrombosis for continued health （REACH） registry［J］. Atherosclerosis, 2009, 204: e86- e92.
［24］ 侯 琳， 王富军，李艳艳，等． 2型糖尿病下肢血管病变患者介入治疗前后缺血动脉内血清超氧化物歧化酶的变化及意义［J］． 介入放射学杂志， 2014， 23： 762- 766．
［25］ 田 浩， 赵金丽， 陈小华， 等． 动态增强磁共振评价糖尿病下肢血管狭窄经皮血管腔内成形术后毛细血管内皮功能变化的研究［J］． 介入放射学杂志， 2014， 23： 13- 17．
相似文献/References:
[1]戴 煌,秦永文,萧 毅.320排动态容积CT冠状动脉成像诊断冠心病的初步应用[J].介入放射学杂志,2012,(07):541.
DAI Huang,QIN Yong- wen,XIAO Yi.. Preliminary application of 320-detector row dynamic volume CT angiography in diagnosing coronary heart diseases[J].journal interventional radiology,2012,(01):541.
[2]罗育坤,范 林,林朝贵,等. 破裂斑块行介入治疗对冠状动脉血流的影响[J].介入放射学杂志,2012,(11):898.
LUO Yu-kun,FAN Lin,LIN Chao- gui,et al. Changes of coronary flow occurred after percutaneous coronary intervention for ruptured plaque detected by intravascular ultrasound[J].journal interventional radiology,2012,(01):898.
[3]潘静薇,陆志刚,张佳胤,等. 冠状动脉介入治疗后迟发型对比剂肾病[J].介入放射学杂志,2013,(01):15.
PAN Jing? wei,LU Zhi? gang,ZHANG Jia? yin,et al. Delayed contrast?蛳 induced nephropathy occurring after percutaneous coronary intervention[J].journal interventional radiology,2013,(01):15.
[4]王智廷,曹国全,闻彩云,等. 冠状动脉介入治疗中操作者所受剂量的综合研究[J].介入放射学杂志,2013,(10):834.
WANG Zhi? ting,CAO Guo? quan,WEN Cai? yun. HUANG Zhou? qing.. The radiation dose to operators in performing percutaneous coronary intervention： a comprehensive study[J].journal interventional radiology,2013,(01):834.
[5]潘春仰,邱建平,陆 林,等.冠状动脉介入治疗后支架内再狭窄相关因素[J].介入放射学杂志,2015,(06):467.
PAN Chun-yang,QIU Jian-ping,LU Lin,et al.Investigation of factors related to the occurrence of in-stent restenosis after percutaneous coronary intervention[J].journal interventional radiology,2015,(01):467.
[6]刘伟宾,黄连军,郭久芳,等.冠心病介入诊疗中透视与电影辐射剂量率对比分析[J].介入放射学杂志,2015,(06):524.
LIU Wei-bin,HUANG Lian-jun,GUO Jiu-fang,et al.Radiation dose rate received by patients with coronary heart disease during interventional management： comparison between fluoroscopy and movies[J].journal interventional radiology,2015,(01):524.
[7]陈 翔,吴丹宁.冠状动脉介入术中球囊致支架损坏1例[J].介入放射学杂志,2018,27(01):96.
CHEN Xiang,WU Danning.Successful management of coronary stent deformation caused by balloon catheter insertion in percutaneous coronary intervention： report of one case[J].journal interventional radiology,2018,27(01):96.
[8]夏 芳,石一夫,梁 洁,等.倾向性评分匹配法评价非ST段抬高型急性冠状动脉综合征介入治疗与保守治疗效果[J].介入放射学杂志,2018,27(08):783.
XIA Fang,SHI Yifu,LIANG Jie,et al.Evaluation of the curative effect of PCI and conservative treatment for non- ST- segment elevation acute coronary syndrome by using propensity score matching method[J].journal interventional radiology,2018,27(01):783.
[9]胡中耀,赵文艺,丁守坤.冠状动脉性心脏病患者经皮冠状动脉介入治疗后脑源性神经营养因子和肾胺酶水平变化及意义[J].介入放射学杂志,2020,29(07):698.
HU Zhongyao,ZHAO Wenyi,Changes of brain-derived neurotrophic factor and renalase levels in patients with coronary heart disease after percutaneous coronary intervention and their clinical significance[J].journal interventional radiology,2020,29(01):698.
[10]刘圣均,权薇薇,张瑞岩.冠心病患者冠状动脉支架植入术后糖代谢异常对非靶病变进展的影响[J].介入放射学杂志,2020,29(08):758.
LIU Shengjun,QUAN Weiwei,ZHANG Ruiyan..Effect of abnormal glucose metabolism on the progression of non-target lesions after coronary stenting in patients with coronary heart disease[J].journal interventional radiology,2020,29(01):758.